Prosecution Insights
Last updated: October 02, 2026

Institució Catalana de Recerca i Estudis Avançats

Technology areas: Biotechnology & Pharmaceuticals • Networking & Security

6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days

Analysis

Institució Catalana de Recerca i Estudis Avançats has 5 pending office actions in the Biotechnology & Pharmaceuticals field. These matters are distributed across 5 distinct art units, showing the technical footprint at the patent office. The use of multiple distinct examiners ensures a range of perspectives during the examination process.

Constantina E Stavrou is the busiest examiner for this portfolio, currently managing 1 pending office action. This distribution means that no examiner or art unit is responsible for more than an individual file.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

6
Total Pending OAs
2
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

4
Hard (67%)
1
Medium (17%)
1
Easy (17%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§101 + other2 (33%)
§102 only1 (17%)
§112 only1 (17%)
Multi-statute (no §101)2 (33%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

3
Life Sciences
50% of docket
2
Information Tech
33% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
1
Mechanical / Eng
17% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

60 h
Manual time on pending OAs
12 h
Time saved (low, 20%)
21 h
Time saved (mid, 35%)
0.5 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
STAVROU, CONSTANTINA E 1 43.7% +36.9%
GELAGAY, SHEWAYE 1 71.9% +45.4%
MUI, CHRISTINE T 1 78.3% +19.9%
KIM, YOUNG J 1 64.8% +18.1%
ABEDIN, SHANTO 1 87.3% +23.1%
WESTFALL, SARAH ANN 1 0.0% +0.0%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18259058 A NETWORK NODE, A TRANSMITTER AND A RECEIVER FOR QUANTUM KEY DISTRIBUTION OVER AN OPTICAL FIBER NETWORK ABEDIN, SHANTO —

Hard Cases (4)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18562448 SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS STAVROU, CONSTANTINA E —
18376681 Optical System for Phase Modulation GELAGAY, SHEWAYE —
18547904 MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY KIM, YOUNG J —
18037191 MEASURING AND IMPROVING ATTENTION WESTFALL, SARAH ANN —

Interview Candidates (5)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 5 ordered by deadline are shown.

App #TitleExaminerDue in
18562448 SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS STAVROU, CONSTANTINA E —
18376681 Optical System for Phase Modulation GELAGAY, SHEWAYE —
18552385 DRUG DISCOVERY ASSAY TO SCREEN FOR COMPOUNDS MUI, CHRISTINE T —
18547904 MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY KIM, YOUNG J —
18259058 A NETWORK NODE, A TRANSMITTER AND A RECEIVER FOR QUANTUM KEY DISTRIBUTION OVER AN OPTICAL FIBER NETWORK ABEDIN, SHANTO —

Top Art Units

Art UnitApps
2400 2
1632 1
1797 1
1681 1
3791 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18562448 SECRETED SPLICING VARIANT OF KLOTHO FOR TREATING BONE DISORDERS STAVROU, CONSTANTINA E 1632 §102§103§112 Non-Final OA — Pending Nov 20, 2023
18376681 Optical System for Phase Modulation GELAGAY, SHEWAYE 2400 §102§112 Final Rejection — Pending Oct 04, 2023
18552385 DRUG DISCOVERY ASSAY TO SCREEN FOR COMPOUNDS MUI, CHRISTINE T 1797 §112 Non-Final OA — Pending Sep 25, 2023
18547904 MARKERS OF PREDICTION OF RESPONSE TO CAR T CELL THERAPY KIM, YOUNG J 1681 §101§112 Final Rejection — Pending Aug 25, 2023
18259058 A NETWORK NODE, A TRANSMITTER AND A RECEIVER FOR QUANTUM KEY DISTRIBUTION OVER AN OPTICAL FIBER NETWORK ABEDIN, SHANTO 2400 §102 Final Rejection — Pending Jun 22, 2023
18037191 MEASURING AND IMPROVING ATTENTION WESTFALL, SARAH ANN 3791 §101§102§112 Final Rejection — Pending May 16, 2023

Managing Institució Catalana de Recerca i Estudis Avançats's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month